Search by Drug Name or NDC

    NDC 43068-0220-01 Hetlioz 20 mg/1 Details

    Hetlioz 20 mg/1

    Hetlioz is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Vanda Pharmaceuticals Inc.. The primary component is TASIMELTEON.

    Product Information

    NDC 43068-0220
    Product ID 43068-220_3248eef5-6bad-4844-a6f9-2f5fddd39c8d
    Associated GPIs 60250070000130
    GCN Sequence Number 072007
    GCN Sequence Number Description tasimelteon CAPSULE 20 MG ORAL
    HIC3 H8B
    HIC3 Description HYPNOTICS, MELATONIN MT1/MT2 RECEPTOR AGONISTS
    GCN 36068
    HICL Sequence Number 040927
    HICL Sequence Number Description TASIMELTEON
    Brand/Generic Brand
    Proprietary Name Hetlioz
    Proprietary Name Suffix n/a
    Non-Proprietary Name tasimelteon
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 20
    Active Ingredient Units mg/1
    Substance Name TASIMELTEON
    Labeler Name Vanda Pharmaceuticals Inc.
    Pharmaceutical Class Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA205677
    Listing Certified Through 2024-12-31

    Package

    NDC 43068-0220-01 (43068022001)

    NDC Package Code 43068-220-01
    Billing NDC 43068022001
    Package 30 CAPSULE in 1 BOTTLE (43068-220-01)
    Marketing Start Date 2014-04-04
    NDC Exclude Flag N
    Pricing Information N/A